Agarwal et al.; ARVO 2018
Evaluationg the Lubricationg Effect of Semifluorinated Alkanes on the Ocular Surface
Eickhoff et al.; ARVO 2018
The Pharmacodynamic Effect of LatanoSol Eye Drops on IOP of Normotensive Dogs
Garhoefer et al.; ARVO 2018
Influence of Perfluorohexyloctane Containing Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease
Kroesser et al.; ARVO 2018
Ocular and Systemic Distribution of 14C-Perfluorohexyloctane Following Topical Ocular Administration to Rabbits
Agarwal et al.; IOIS 2017
Semifluorinated Alkanes Enhance the Lipid Layer for Dry Eye Therapy
Fischer et al.; EVER 2017
Exploratory Ocular Surface Distribution Studies of Azithromycin Formulations Based on Semifluorinated Alkanes
Torkildsen et al.; AAO 2017
A Clincal Phase 2 Study to Assesss Safety, Efficacy, and Tolerability of CyclASol® for the Treatment of Dry Eye Disease
Agarwal et al.; EVER 2016
Semi-Fluorinated Alkanes for Topical Delivery of Cyclosporine A
Gehlsen et al.; ARVO 2016
Omega-3 Fatty Acids Using F6H8-Carrier as Topical Therapy in Experimental Dry Eye Disease
Kaercher et al.; TFOS 2016
NovaTears® as New Therapy in Dry Eye: Results frorm Three Prospective, Multicenter, Non-Interventional Studies in Different Patient Populations
Messmer et al.; DOG 2016
Semifluorierte Alkane als Therapie bei Meibomdrüsen-Dysfunktion: Ergebnisse einer prospektiven, multizentrischen Beobachtungsstudie
Gehlsen et al.; ARVO 2015
Cyclosporine A Using F4H5 as Liquid Drug Carrier is Effectie in Treating Experimental Dry Eye Disease